Community
Company
News
Contact Us
Sign in

Please select the option that best describes you:

Topics: Rheumatology • Spondyloarthritis

What is your experience with using oral roflumilast for psoriatic arthritis?

Related Questions

For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?

How do you incorporate disease activity scores and remission targets for axial spondyloarthritis to determine timing and frequency of treatment adjustments?

How do you approach inflammatory arthralgias without synovitis in a patient with psoriasis?

What treatment strategies would you utilize in a patient with newly diagnosed HLA-B27+ axial spondyloarthritis (with active and chronic sacroiliitis on MRI) and recent diagnosis of MS that is well-controlled MS ocrelizumab given the need to avoid TNF inhibitors?

How would you approach treatment of active axial spondyloarthritis refractory to NSAID in a patient with concurrent autoinflammatory disease on long-term anti-IL-1 therapy?

For ICI arthritis, how soon do you start DMARDs?

Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?

How would you manage active axial spondyloarthritis in a patient with recent (<5 years) solid malignancy who completed chemotherapy?

What is your approach to use of IL-17 inhibitors in patients with axial spondyloarthritis and a family history of inflammatory bowel disease?

What would be your treatment approach for a patient with concomitant diagnoses of multiple myeloma and axial spondyloarthritis?

Copyright © 2026 theMednet
All Rights Reserved.